Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
---|---|---|---|---|---|---|---|
Alkermes plc | 12 | 2 | 1 | 0 | €22.00 | €34.08 | 54.912% |
Medpace Holdings Inc | 9 | 0 | 3 | 0 | €364.50 | €421.61 | 15.667% |
Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €11.99 | €22.78 | 89.952% |
Ensign Group Inc. | 8 | 0 | 1 | 0 | €110.00 | €116.50 | 5.906% |
United Therapeutics | 18 | 0 | 3 | 0 | €240.90 | €288.66 | 19.826% |
Taro Pharmaceutical Industries Ltd | 7 | 0 | 1 | 0 | €39.40 | - | - |
Merit Medical Systems | 16 | 0 | 5 | 0 | €70.50 | €86.90 | 23.258% |
Select Medical Holdings | 4 | 0 | 2 | 0 | €26.00 | €36.41 | 40.025% |
Haemonetics Corp. | 7 | 0 | 1 | 0 | €84.50 | €97.90 | 15.860% |
Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €99.52 | - | - |
Integer Hldg | 1 | 0 | 0 | 0 | €101.00 | - | - |
Korian S.A. | 1 | 0 | 1 | 0 | €2.35 | - | - |
Amedisys Inc. | 13 | 0 | 0 | 0 | €84.00 | €92.26 | 9.833% |
Icon plc | 18 | 0 | 6 | 0 | €280.90 | €318.99 | 13.562% |
QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
LivaNova plc | 9 | 0 | 3 | 0 | €57.00 | €66.59 | 16.829% |
Icu Medical Inc. | 3 | 0 | 0 | 0 | €90.50 | €124.85 | 37.953% |
Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
Bio-Techne Corp. | 10 | 0 | 2 | 0 | €72.00 | €75.80 | 5.282% |
Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
Charles River Labs Intl | 9 | 0 | 0 | 0 | €214.40 | €247.61 | 15.489% |
Exelixis Inc. | 17 | 0 | 2 | 0 | €20.62 | €25.64 | 24.322% |
Neurocrine Bioscience | 27 | 0 | 7 | 0 | €130.30 | €140.34 | 7.705% |
Tenet Healthcare | 28 | 0 | 7 | 0 | €111.00 | €118.36 | 6.635% |
Catalent Inc. | 2 | 0 | 0 | 0 | €52.32 | €55.00 | 5.122% |